PMID: 11335066May 4, 2001Paper

Polyamines in the basal ganglia of human brain. Influence of aging and degenerative movement disorders

Neuroscience Letters
M VivóE Martínez

Abstract

The distribution of polyamines in the human basal ganglia was examined, using dansyl-derivatives and high pressure liquid chromatography with fluorimetric detection. A heterogeneous distribution of putrescine, spermidine (SD) and spermine (SM) was observed in control brains. A consistent negative correlation between SD and SM content and age was found in different brain areas. These results suggest an involvement of polyamines in age-related changes occurring in white-matter. When the influence of degenerative movement disorders -Parkinson's disease, Huntington's disease (HD) and progressive supranuclear palsy- was analyzed, significant changes were observed only in HD, where a decrease in the concentration of SM was found in the putamen. These results suggest that in advanced stages of neurodegenerative processes, polyamines maintain their regulation. Only in the presence of severe atrophy, SM concentration is reduced.

References

Jun 1, 1992·Molecular and Chemical Neuropathology·W Paschen
Jan 1, 1991·Life Sciences·E MartínezF Artigas
Jul 22, 1988·Science·S W Davies, P J Roberts
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·D M Rock, R L Macdonald
Sep 1, 1995·Neuroscience Letters·L D Morrison, S J Kish
Oct 18, 2000·Journal of Neurochemistry·J DotJ Rodríguez-Alvarez

❮ Previous
Next ❯

Citations

Sep 1, 1983·Journal of the Neurological Sciences·R A Roos, G T Bots
Jul 30, 2003·Brain Research·Angelika Richter, Lesley D Morrison
Aug 13, 2008·The Journal of Physical Chemistry. B·Megan GrabenauerMichael T Bowers
Sep 27, 2013·Nature Neuroscience·Ronald L Davis
Sep 7, 2012·Rejuvenation Research·Stefania PucciarelliValerio Napolioni
Jun 3, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Man-Jeong PaikGwang Lee
Apr 22, 2008·Journal of Neurochemistry·Thomas M JeitnerArthur J L Cooper
Jul 9, 2004·Journal of the Neurological Sciences·Titti EkegrenHåkan Askmark
Dec 9, 2014·Cell Cycle·Sabrina BüttnerFrank Madeo
Jul 15, 2015·Journal of Molecular Biology·Leonor Miller-FlemingMarkus Ralser
Jun 18, 2015·Molecular Neurobiology·Matic PavlinJanez Mavri
Jan 24, 2019·Cell Biology and Toxicology·Bejoy VijayanAnoopkumar Thekkuveettil
Jun 4, 2019·Annals of Neurology·Shinji SaikiNobutaka Hattori
Nov 19, 2002·The Journal of Biological Chemistry·Thomas AntonyVinod Subramaniam
Jul 8, 2020·Annual Review of Nutrition·Frank MadeoGuido Kroemer
Dec 25, 2019·Scientific Reports·Marta MaglioneStephan J Sigrist
Feb 12, 2020·Biochimica Et Biophysica Acta. General Subjects·Ayesha KabirGopinatha Suresh Kumar
Sep 3, 2020·Neuropeptides·Indrani GhoshMadhavan Nampoothiri
Nov 14, 2002·Experimental Neurology·C Gomes-TrolinH Askmark
Mar 21, 2013·ACS Chemical Neuroscience·Jinghui LuoSebastian K T S Wärmländer
Oct 16, 2021·NPJ Parkinson's Disease·Stephan KlattBlaine R Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.